Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels (Q39025763)
Jump to navigation
Jump to search
scientific article published on 24 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels |
scientific article published on 24 March 2015 |
Statements
1 reference
Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels (English)
1 reference
Tait D Shanafelt
1 reference
Tim G Call
1 reference
Susan L Slager
1 reference
Kari G Chaffee
1 reference
Neil E Kay
1 reference
Bijan J Borah
1 reference
Heidi D Finnes
1 reference
Wei Ding
1 reference
Jose F Leis
1 reference
Asher A Chanan-Khan
1 reference
Sameer A Parikh
1 reference
24 March 2015
1 reference
1 reference
11
1 reference
3
1 reference
252-258
1 reference
Identifiers
1 reference
1 reference